ARTIS Ventures
Capital Type
Venture Capital
Investment Size
Undisclosed / varies by deal
Geographic Scope
US, Global
Return Model
Dilutive
Stage Focus
Seed to Growth
Modality Focus
Phage / CRISPR antimicrobials, Frontier tech
Overview
Frontier-tech and health investor with a documented lead investment in Locus Biosciences, a precision antimicrobial company.
Portfolio and Signals
Especially relevant for non-traditional AMR modalities where platform novelty and frontier technology matter.
Access and Engagement
Access is highly thesis- and founder-driven.
Notable AMR Examples / Programs
Locus Biosciences
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
